Consensus Abbott Laboratories Deutsche Boerse AG

Stocks

ABL0

CA0028221046

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 07:15:03 30/10/2026 pm IST			5-day change	1st Jan Change
11.80 ^EUR	+3.51%		+4.42%	-11.94%

30/10	Perrigo to sell infant formula business to MeridianMade for up to $175 million	RE
29/10	Perrigo to sell infant formula business to MeridianMade for up to $175 million	RE

301d6c6e47fbfb8a41f0b.1Hb6Q-9hrotpIdZd_p4NaMQRxoJ41HxBBolEnSEHkwQ.tjisLtszyucdbKxptds0AIFWt8pN4Ch1QMIczk43o0KWMZYRtUzr-CIM4g~13985ce074e62de677bb17e224f7dac6

Analysts' recommendations: Abbott Laboratories

27/10	Abbott Laboratories Shares Fall After Argus Downgrade	MT
27/10	Argus Downgrades Abbott Laboratories to Hold From Buy	MT
22/10	Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says	MT
22/10	Jefferies & Co Adjusts Abbott Laboratories Price Target to $130 From $135	MT
22/10	RBC Trims Price Target on Abbott Laboratories to $125 From $130, Keeps Outperform Rating	MT
22/10	Leerink Partners Adjusts Price Target on Abbott Laboratories to $106 From $109	MT
22/10	BTIG Adjusts Price Target on Abbott Laboratories to $125 From $134	MT
22/10	Wells Fargo Adjusts Price Target on Abbott Laboratories to $119 From $112	MT
22/10	JPMorgan Adjusts Price Target on Abbott Laboratories to $118 From $120	MT
22/10	TD Cowen Adjusts Price Target on Abbott Laboratories to $118 From $135	MT
20/10	Abbott Laboratories' Established Pharma Unit Undervalued on Biosimilars Potential, UBS Says	MT
07/10	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
05/10	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
02/10	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
02/10	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
02/10	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
21/08	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
13/08	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
28/07	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
28/07	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
23/07	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
22/07	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
17/07	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
17/07	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+13.34%
	STRYKER CORPORATION					+16.32%
	MEDTRONIC PLC					+7.73%
	ESSILORLUXOTTICA					+21.16%
	CENCORA, INC.					+11.66%
	HOYA CORPORATION					+16.36%
	BECTON, DICKINSON AND COMPANY					-1.4%
	IDEXX LABORATORIES, INC.					+20.56%
	ALCON INC.					+26.66%
	Average					+14.71%
	Weighted average by Cap.					+13.94%